ASGCT Education Program Returns, Covers Parkinson's Disease

ASGCT Staff | October 10, 2019

ASGCT is proud to launch a second round of disease-specific resources in its Patient Education program. The first of the seven new resources focuses on developing gene therapies for Parkinson’s disease.

ASGCT News   |   Education
Read Full Story

Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles

ASGCT Staff | June 26, 2019

Parent journal, Molecular Therapy, now tops the field with a 19.9 percent jump in impact factor to 8.402.

ASGCT News   |   Molecular Therapy
Read Full Story

ASGCT Heats Up in Summer 2019

Maritza McIntyre, Ph.D. | June 14, 2019

Up-to-date clinical trials info and a new policy-centered event keep up the post-meeting momentum.

Advocacy   |   ASGCT News
Read Full Story

FDA Approves Zolgensma, Landmark AAV-Delivered Gene Therapy to Treat Spinal Muscular Atrophy

May 24, 2019

Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat spinal muscular atrophy (SMA) also known as AVXS-101, was approved for clinical use in the United States by the Food and Drug Administration today. 

Annual Meeting 2019   |   ASGCT News   |   Gene Therapy Approval
Read Full Story

The Case for Growth

Guangping Gao, Ph.D. | May 09, 2019

Following a record-breaking ASGCT Annual Meeting, the Society is ready to branch out and ensure its growth is sustainable.

Annual Meeting 2019   |   ASGCT News   |   President's Message
Read Full Story

ASGCT To Honor Four Ground-Breaking Researchers at 22nd Annual Meeting

ASGCT Staff | March 26, 2019

ASGCT is proud to introduce the four recipients of the Society's 2019 Outstanding Achievement Award, Outstanding New Investigator Awards, and the Sonia Skarlatos Public Service Award.

Annual Meeting 2019   |   ASGCT News
Read Full Story

ASGCT Selects First-Ever Career Development Grant Group, Awards Total $245,000

ASGCT Staff | January 07, 2019

The American Society of Gene and Cell Therapy’s (ASGCT) first class of 14 career development grant recipients were named by a selection committee made up of industry leaders identified by the ASGCT board of directors. In total, the Society will distribute $245,000.

ASGCT News   |   Funding
Read Full Story

Portrait courtesy of St. Jude Children's Research Hospital.

Remembering Dr. Brian Sorrentino

Phil Doerfler, Ph.D. | December 12, 2018

Gene therapy pioneer Brian Sorrentino, M.D., passed away in November. Thanks to Brian’s efforts, patients with X-SCID who received gene therapy are returning home and leading healthy lives. He will be missed and remembered fondly.

Read Full Story

ASGCT Giving Tuesday and It's (Probably) Time to Renew Your Membership

Jennifer Adair, Ph.D. | November 08, 2018

Don’t miss out on your chance to be part of our collective progress. Act now to ensure your ASGCT membeship is up to date and please consider including ASGCT in your Giving Tuesday efforts.

Read Full Story

President's Message—Abstracts, Value Summit, and ESGCT

Michele Calos, Ph.D. | October 09, 2018

The abstract collection is the lifeblood of ASGCT’s Annual Meeting, and the Society is excited to feature the future of our field at the Washington Hilton next year. I encourage all of you to consider submitting your research to the ASGCT Annual Meeting.

ASGCT News   |   President's Message
Read Full Story

ASGCT Releases Anti-Harassment Policy

Dr. Nicole K. Paulk, Ph.D. | August 03, 2018

The fields of gene and cell therapy are strongest when all members are supported by positive, safe, and healthy work environments. To reinforce a healthy environment for all, the ASGCT Trainee and Executive committees established a new mandatory anti-harassment and non-discrimination policy for all ASGCT events.

Read Full Story

ASGCT Submits Comment on CAR T-Cell Therapy Coverage and Reimbursement

ASGCT Staff | July 26, 2018

ASGCT submitted comments last month to the Centers for Medicare & Medicaid Services (CMS) on Medicare coverage and reimbursement of CAR T-cell therapies as part of the Society’s effort to improve access to approved gene therapies.

ASGCT News   |   Policy Updates
Read Full Story

Remembering Dr. George Stamatoyannopoulos

July 25, 2018

Scientist and physician George "Dr. Stam" Stamatoyannopoulos, M.D., Dr. Sci, who conceptualized and helped create the American Society of Gene & Cell Therapy in 1996, died June 16, 2018. To those who knew Dr. Stamatoyannopoulos, he was a friend, mentor, leader, and brilliant scientist.

Read Full Story

ASGCT Offers Up To $245,000 in Career Development Grants

ASGCT's New Investigator and Trainee Committees | June 11, 2018

In support of trainees and members developing their careers, the American Society of Gene & Cell Therapy will distribute up to 14 grants worth a total of $245,000 in 2018. Applications are accepted through August 1.

ASGCT News   |   Funding
Read Full Story

President's Message—June 2018

Michele Calos, M.D. | June 11, 2018

Michele Calos, Ph.D. recaps the stunningly successful 21st ASGCT Annual Meeting and announces the opening of the Society's Career Development Grant program in her first address as ASGCT president.

ASGCT News   |   President's Message
Read Full Story

2018 Annual Meeting By the Numbers

ASGCT Staff | May 31, 2018

The American Society of Gene & Cell Therapy's 22nd Annual Meeting was the Society's largest in history. Check out some of the highlight stats from the May event.

Annual Meeting 2018   |   ASGCT News
Read Full Story

ASGCT Policy Summit

November 4 – 6 | Washington D.C.